|Previous Section||Index||Home Page|
Mrs. Iris Robinson: To ask the Secretary of State for Northern Ireland how many cases of (a) Clostridium difficile and (b) vancomycin-resistant enterocuccus have been reported in each health trust in the Province in each month of the last three years. 
(a) Mandatory surveillance for Clostridium difficile only commenced in Northern Ireland on 1 January 2005. Hospital laboratory reports are filtered and data on over 65-year-olds are then analysed on a quarterly basis.
|Number of Clostridium difficile patient episodes reported to the Communicable Disease Surveillance Centre (NI) by trust and quarter( 1)|
|Trust||January-March 2005||April-June 2005||July-September 2005|
|(1) All data provisional|
(b) The number of vancomycin-resistant blood isolates of enterococci has been collated through voluntary laboratory reporting in Northern Ireland since 1 January 2003. Each laboratory may serve a number of different Trusts, including acute, specialist and community trusts. The following table shows the number of reports since 2003 compiled by the Communicable Disease Surveillance Centre (NI).
Mrs. Iris Robinson: To ask the Secretary of State for Northern Ireland how many healthcare-acquired infections there were within each health trust in the Province in each month of the last three years. 
Paul Goggins: It is not feasible to have active surveillance of all healthcare associated infections (HCAIs). Currently there are three mandatory HCAI surveillance programmes in Northern Ireland on Clostridium difficile, Staphylococcus aureus (and MRSA) bacteraemias, and orthopaedic surgical site infections. When collated, these act as markers for the level of HCAI found in hospitals.
Mrs. Iris Robinson: To ask the Secretary of State for Northern Ireland how many cases of MRSA have been reported within each health trust in the Province in each month of the last three years. 
Statistics on MRSA bacteraemias are recorded quarterly by trust and are provided in the following table. The results collated are of infections which have been identified by testing within a hospital. However, no distinction can be made between where the infection
was actually acquired, i.e. in hospital or in the community. Trusts with different clinical mixes and specialties will have differing proportions of patients at high risk of infection.
|Trust||January to March 2004||April to June 2004||July to September 2004||October to December 2004||January to March 2005||April to June 2005||July to September 2005|
|Trust||July to September 2002||October to December 2002||January to March 2003||April to June 2003||July to September 2003||October to December 2003|
|Next Section||Index||Home Page|